Recent Articles from GlobeNewswire

MONTREAL and NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- NorthStar Earth & Space Inc. (“NorthStar” or the “Company”), a global leader in Space Situational Awareness (“SSA”) and Space Domain Awareness (“SDA”), and Viking Acquisition Corp. I (“Viking”) (NYSE: VACI), a special purpose acquisition company, announced that they have entered into a definitive business combination agreement (the “Business Combination Agreement”). Upon closing of the transaction, shares of the combined company are expected to trade on the New York Stock Exchange under the ticker “NSTR”.

BEIJING, China, April 17, 2026 (GLOBE NEWSWIRE) -- Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced that it has published its 2025 Environmental, Social and Governance (“ESG”) Report (the “Report”).

Targets rare, high-burden genetic condition with no approved therapies; advances non-surgical treatment strategy for recurrent basal cell carcinoma

Approximately $10 Million To Be Funded at First Closing; 24-Month Commitment Period Provides Dedicated Capital to Execute on Active M&A Pipeline Currently focused on Aerospace, Defense, and Industrial Manufacturing

Singapore, April 17, 2026 (GLOBE NEWSWIRE) -- WEBUY GLOBAL LTD. (Nasdaq: WBUY) (“Webuy” or the “Company”), a technology-driven comprehensive travel solutions company, today announced the successful launch of its latest premium travel offering under Altitude Travel, the Company’s high-end travel brand, featuring an exclusive chartered Antarctica expedition cruise experience that generated over US$777,500 in total transaction value within its first month of launch. This launch supports the Company’s strategy to expand its premium, experience-led travel offerings targeting high-value customers.

MELBOURNE, Australia and SAN FRANCISCO, April 17, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the appointment of Ms Ann Cunningham to its Board of Directors as an independent Non-Executive Director, effective 17th April 2026. Ms Cunningham’s appointment further strengthens Alterity’s Board composition, adding significant global commercial and strategic expertise as the Company transitions toward late-stage development in Multiple System Atrophy (MSA).

Chris Buescher’s Liverpool FC Inspired Paint Scheme to Debut at ‘Premier League Mornings Live’ Fan Festival in Tampa, April 18-19

BEIJING, China, April 17, 2026 (GLOBE NEWSWIRE) -- Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission on April 17, 2026. The annual report can be accessed on the Company’s investor relations website at https://ir.zhihu.com.

FREMONT, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- In the wake of the new 2026 Sidley Blockchain Bulletin, which highlights tokenized Real-World Assets (RWAs) as the next frontier for capital markets, Dmitry Shubov Consulting is releasing a new strategic analysis focused on the "compliance gap" hitting Southeast Asian (SEA) startups. With the June 3, 2026, New York UCC Article 12 rollout just around the corner, the briefing delves into the new "exclusive control" rules that these firms must meet if they want to turn their digital assets into legitimate collateral for U.S. bank financing.

Seasoned Critical Minerals and Specialty Chemicals Executive to Drive Commercial Strategy Across USA Rare Earth’s Integrated Value Chain

SINGAPORE, April 17, 2026 (GLOBE NEWSWIRE) -- Intchains Group Limited (Nasdaq: ICG) (“we,” or the “Company”), a company focuses on the development of altcoin mining products, the strategic acquisition, holding, and staking of Ethereum-based cryptocurrencies, and the delivery of Web3 infrastructure services through the operation of a Proof-of-Stake cryptocurrency staking platform, today provided an update on its Ethereum (“ETH”) staking activities, and announced the advancement of its strategic transformation through the adoption of an AI-enabled operating model.

LONDON, April 17, 2026 (GLOBE NEWSWIRE) -- Yaqrit, a late clinical-stage company developing life-saving treatments for advanced liver diseases, today announce three international clinical papers outlining key, market-moving shifts in scientific evidence and clinical practice in hepatic encephalopathy (HE). HE is brain dysfunction that occurs in patients with advanced liver disease and is associated with accumulation of the toxin, ammonia. Between them, the three papers reinforce Yaqrit’s strategy for the development of its novel HE treatments, as they approach late-stage clinical trials. YAQ006 and YAQ007, IV and oral formulations of OPA, an ammonia-scavenging agent, are preparing for further clinical studies later this year.

Allentown, PA, April 17, 2026 (GLOBE NEWSWIRE) -- CrossAmerica Partners to Announce

BEIJING, April 17, 2026 (GLOBE NEWSWIRE) -- Niu Technologies (“NIU” or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission. The annual report on Form 20-F can be accessed on the Company’s investor relations website at https://ir.niu.com/.

LIAOCHENG, China, April 17, 2026 (GLOBE NEWSWIRE) -- Over 700 agricultural enterprises, research institutions, and international exhibitors converged on Wednesday at the Shenxian County Convention Center in Liaocheng City for the opening of the 2nd Shandong Green Vegetable Industry Expo, an event highlighting China's accelerating shift toward technology-driven, sustainable farming.

SHANGHAI, April 17, 2026 (GLOBE NEWSWIRE) -- Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading lifestyle group in China, today announced that the Company has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”) on April 17, 2026.

Sales Highlights (unaudited):

Data from subset analysis of cabozantinib-pretreated patients support potential to overcome resistance and resensitize tumors to VEGF TKI therapy

VENICE, Fla., April 17, 2026 (GLOBE NEWSWIRE) -- Freedom Boat Club, the world’s largest boat club and a Brunswick Corporation (NYSE: BC) business, today announced it has acquired the Freedom Boat Club of Greater Boston & Cape Cod franchise operations, the largest current franchise in the Freedom network. 

VANCOUVER, British Columbia, April 17, 2026 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (TSX: FVI) (NYSE: FSM) (“Fortuna” or the “Company”) announced today that its Board of Directors has approved the renewal of its normal course issuer bid (“NCIB”) to purchase up to five percent of its outstanding common shares as at April 10, 2026.

VEON to Release 1Q26 Earnings Update on May 13, 2026

New York, NY, April 17, 2026 (GLOBE NEWSWIRE) -- ScaleTime, a leading operational intelligence consulting firm, announces the launch of its Pulse Dash, a powerful data dashboard and performance intelligence solution designed to help small and medium businesses turn scattered data into clear, actionable insights. By integrating key metrics across operations, sales, marketing, and finance into a single system, Pulse Dash enables leaders to move from reactive decision-making to proactive, data-driven leadership.

Gosselies, Belgium, 17 APRIL 2026 (08:30 CET) – Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, has appointed three additional internationally respected neurovascular experts to its Clinical Advisory Board. The nominations come as Bioxodes is in dialogue with regulators to design the pivotal clinical trial of BIOX-101 to treat intracerebral hemorrhage (ICH), an urgent unmet medical need.

Dallas-based firm equips high-income investors with structured guidance on direct energy participation, tax frameworks, and due diligence considerations

Featuring the revolutionary DynaCore System, Sihoo's newest flagship chair eliminates support loss during movement and delivers truly adaptive, personalized comfort

FREMONT, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, today announced the pricing of its upsized initial public offering of 11,250,000 shares of its common stock at a public offering price of $17.00 per share. In addition, Alamar has granted the underwriters a 30-day option to purchase up to an additional 1,687,500 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on April 17, 2026 under the ticker symbol “ALMR.” The gross proceeds from the offering are expected to be approximately $191.3 million, without giving effect to the underwriters’ option to purchase additional shares and before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on April 20, 2026, subject to the satisfaction of customary closing conditions.

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Enters into Cooperation Agreement with Altai Capital

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION TO THE UNITED STATES

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) --

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) --

WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced the pricing of its initial public offering of 39,062,500 shares of its common stock at a price to the public of $16.00 per share. All of the shares of common stock are being offered by Kailera. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Kailera, are expected to be $625.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. Kailera’s common stock is expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “KLRA” on April 17, 2026. The offering is expected to close on April 20, 2026, subject to the satisfaction of customary closing conditions. In addition, Kailera has granted the underwriters a 30-day option to purchase up to an additional 5,859,375 shares of common stock at the initial public offering price less underwriting discounts and commissions.

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) --

MARKHAM, Ontario, April 16, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual meeting of shareholders held on April 16, 2026 (the “Meeting”). The voting results for each of the matters considered at the Meeting are presented below.

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) --

WESTFIELD, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- JATT II Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 6,000,000 ordinary shares at an offering price of $10.00 per ordinary share. The ordinary shares are expected to trade on the Nasdaq Global Market (“NASDAQ”) under the ticker symbol “JATT” beginning April 17, 2026. The offering is expected to close on April 20, 2026, subject to customary closing conditions.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Coty To Contact Him Directly To Discuss Their Options

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) --

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) --

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Super Mirco (SMCI) To Contact Him Directly To Discuss Their Options

SAN ANTONIO, April 16, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT) a leading end-to-end hybrid cloud and AI solutions company, today announced that it will release its first quarter 2026 financial results at 8:00 am ET on Thursday, May 7, 2026. Gajen Kandiah, Chief Executive Officer, and Mark Marino, Chief Financial Officer, will host a conference call on the day of the release (May 7, 2026) at 8:30 am ET to discuss the Company’s financial results.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hercules Capital (HTGC) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Power Solutions (PSIX) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Medpace (MEDP) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Concorde (CIGL) To Contact Him Directly To Discuss Their Options

Omaha, Nebraska, April 16, 2026 (GLOBE NEWSWIRE) -- Scoular announced today that Grain Division Vice President and General Manager Phil Van Court has been promoted to company president, effective June 1.

Sanuwave is pleased to announce preliminary revenues of $9.6 million to $9.7 million for the first quarter ended March 31, 2026, in line with prior guidance for Q1.

ST. GALLEN, Switzerland, April 16, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (Nasdaq: SRAD) (“Sportradar”) will release its financial and operating results for the first quarter ended March 31, 2026, on Wednesday, May 6, 2026. Sportradar will also host an earnings call via webcast to discuss the results at 8:30 a.m. Eastern Time on Wednesday, May 6, 2026.

SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today announced that it will release its financial results for the first quarter, ended March 31, 2026, after the market closes on May 7, 2026.

ISTANBUL, April 16, 2026 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce platform, will report its unaudited financial results for the first quarter ending March 31, 2026 after the U.S. market closes on Thursday, May 7, 2026.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In B&W (BW) To Contact Him Directly To Discuss Their Options

MONTEVIDEO, Uruguay, April 16, 2026 (GLOBE NEWSWIRE) -- DLocal Limited (NASDAQ: DLO, “dLocal” or the “Company”), the leading cross-border payment platform connecting global merchants to emerging markets, today announced a change to the time of its previously scheduled earnings conference call.

LONG BEACH, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced that it will release its financial results for the first quarter 2026 following the close of the U.S. markets on Thursday May 7, 2026. Rocket Lab will host a corresponding conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

Recognition highlights Hughes completeness of vision and ability to execute

AUSTIN, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver seamless, personalized experiences at scale, today announced it will report its financial results for the first quarter ended March 31, 2026, before market open on Thursday, May 7, 2026.

AUDUBON, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2026 after the market close on Thursday, May 7, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.

CASTLE ROCK, Colo., April 16, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, announced today that it has scheduled its first quarter 2026 earnings conference call for Thursday, April 30, 2026, at 4:30 P.M. EST.

COLUMBUS, Ohio, April 16, 2026 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), the leading technology company in car insurance, today announced its plans to host a conference call on Wednesday, May 6, 2026 at 5:00 p.m. Eastern Time to discuss financial results for the first quarter 2026 and provide an update on company operations. The company plans to release its first quarter results in the Investor Relations section of its website at ir.joinroot.com following the close of the financial markets on Wednesday, May 6, 2026.

Latest rollout broadens Gaxos’ generative AI markets as expanded capabilities fuel user activity and platform momentum

SCOTTSDALE, Ariz., April 16, 2026 (GLOBE NEWSWIRE) -- onsemi (Nasdaq: ON) plans to announce its financial results for the first quarter, which ended April 3, 2026, after market close on Monday, May 4, 2026.

WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases, today announced the closing of its previously announced underwritten public offering of 7,475,000 shares of its common stock, including the full exercise of the underwriters’ option to purchase up to 975,000 additional shares, at a public offering price per share of $62.00. The gross proceeds to Spyre from the offering were approximately $463.5 million before deducting underwriting discounts and commissions and other offering expenses payable by Spyre.

Las Vegas, Nevada, April 16, 2026 (GLOBE NEWSWIRE) -- SUMA Acquisition Corporation (Nasdaq: SUMAU) (the “Company”) announced today that, commencing April 20, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and rights included in the units. No fractional rights will be issued upon separation of the units and only whole rights will trade. The Class A ordinary shares and rights that are separated will trade on the Nasdaq Global Market under the symbols “SUMA” and “SUMAR,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “SUMAU.”

INDIANAPOLIS, April 16, 2026 (GLOBE NEWSWIRE) -- Kite Realty Group (NYSE: KRG) (“KRG” or the “Company”) today announced a deepening of its leadership team across operations, technology and finance – a direct investment in platform capabilities to sustain execution intensity and accelerate long-term value creation.

SCOTTSDALE, Ariz., April 16, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its first quarter 2026 earnings release before the market opens on Thursday, May 7, 2026.

MINNEAPOLIS, April 16, 2026 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), the leading intelligent supply chain network, today announced that it will issue its financial results for the first quarter ended March 31, 2026, after the market close on Thursday, April 30, 2026. SPS Commerce will host a call to discuss the results at 3:30 p.m. Central Time (4:30 p.m. Eastern Time) on the same day.

ISELIN, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Middlesex Water Company (NASDAQ: MSEX) plans to report its financial results for the first quarter ended March 31, 2026, after the market closes on Thursday, April 30, 2026. The press release and the company’s first quarter 2026 Form 10-Q filing will be available in the Investors section of the company’s website.

MCLEAN, Va., April 16, 2026 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) today announced that it will release financial results for the first quarter ended March 31, 2026, before the U.S. financial markets open on Thursday, May 7, 2026. The company will host a conference call and live webcast to review its financial results and business outlook.

EASTON, Md., April 16, 2026 (GLOBE NEWSWIRE) -- TeraWulf Inc. (NASDAQ: WULF) (the “Company” or “TeraWulf”) today announced the closing of its previously announced public offering of 54,510,000 shares of its common stock (the “Offering”) at a price of $19.00 per share, including the full exercise by the underwriters of their option to purchase up to an additional 7,110,000 shares of common stock.

SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2026 after the close of trading on Thursday, April 30, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

WARSAW, Ind., April 16, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2026 financial results on Thursday, April 30, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, April 30, 2026 at 4:30 p.m. ET to discuss the results.

GAITHERSBURG, Md., April 16, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 30, 2026, at 5:00 p.m. eastern time to discuss the financial results for the first quarter of 2026.

Refinancing extends maturities, reduces interest expense and positions Emergent for durable, long-term growth as part of its multi-year transformation plan

PRINCETON, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (the “Company”) today reminds all stockholders to vote “FOR” the proposal to amend and restate the Company’s certificate of incorporation (the “Charter Amendment Proposal”), as recommended by the Board of Directors of the Company (the “Board”), to simplify the Company’s public share class structure into a single share class at this year’s Annual Meeting of Stockholders (the “Annual Meeting”) scheduled to take place on April 29, 2026. Stockholders are encouraged to visit www.votefor.clearwayenergy.com for more information on the Charter Amendment Proposal and how to vote.If approved, the Charter Amendment Proposal is expected to benefit stockholders by enhancing the appeal of the Company’s stock and increasing stockholder value.

Company highlights ongoing transition toward a broader multi-platform portfolio supported by new indie releases, expanding partnerships, and long-term AAA development roadmap

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Datadog, Inc. (NASDAQ:DDOG), the AI-powered observability and security platform for cloud applications, today announced that it will report its first quarter fiscal year 2026 financial results before the U.S. financial markets open on Thursday, May 7, 2026.